News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
578,986 Results
Type
Article (47557)
Company Profile (126)
Press Release (531303)
Section
Business (170085)
Career Advice (1625)
Deals (27654)
Drug Delivery (112)
Drug Development (77932)
Employer Resources (112)
FDA (17031)
Job Trends (12377)
News (301088)
Policy (32942)
Tag
Academia (2155)
Alliances (45178)
Alzheimer's disease (1293)
Antibody-drug conjugate (ADC) (116)
Approvals (16955)
Artificial intelligence (178)
Bankruptcy (259)
Best Places to Work (9647)
Breast cancer (199)
Cancer (1516)
Cardiovascular disease (126)
Career advice (1393)
CAR-T (108)
Cell therapy (311)
Clinical research (62640)
Collaboration (595)
Compensation (173)
COVID-19 (2472)
C-suite (118)
Data (1423)
Diabetes (201)
Diagnostics (4883)
Drug pricing (114)
Earnings (69539)
Events (82976)
Executive appointments (445)
FDA (17868)
Funding (475)
Gene therapy (227)
GLP-1 (716)
Government (4267)
Healthcare (15192)
Infectious disease (2569)
Inflammatory bowel disease (115)
Interviews (276)
IPO (12713)
Job creations (3124)
Job search strategy (1182)
Layoffs (428)
Legal (7211)
Lung cancer (229)
Manufacturing (211)
Medical device (10465)
Medtech (10470)
Mergers & acquisitions (15181)
Metabolic disorders (556)
Neuroscience (1676)
NextGen: Class of 2025 (5326)
Non-profit (3576)
Northern California (1608)
Obesity (320)
Opinion (236)
Patents (137)
People (45410)
Phase I (18962)
Phase II (27077)
Phase III (21310)
Pipeline (624)
Policy (105)
Postmarket research (2979)
Preclinical (7958)
Radiopharmaceuticals (223)
Rare diseases (308)
Real estate (4463)
Regulatory (23163)
Research institute (2040)
Resumes & cover letters (242)
Southern California (1456)
Startups (2891)
United States (14593)
Vaccines (592)
Weight loss (248)
Date
Today (93)
Last 7 days (535)
Last 30 days (2207)
Last 365 days (31022)
2025 (2184)
2024 (31375)
2023 (35083)
2022 (44517)
2021 (47442)
2020 (45564)
2019 (38818)
2018 (29556)
2017 (28942)
2016 (27782)
2015 (31648)
2014 (25910)
2013 (22076)
2012 (23254)
2011 (23264)
2010 (22043)
Location
Africa (776)
Arizona (120)
Asia (36293)
Australia (5927)
California (3716)
Canada (1383)
China (357)
Colorado (173)
Connecticut (190)
Europe (79633)
Florida (568)
Georgia (137)
Illinois (350)
Indiana (217)
Maryland (643)
Massachusetts (2754)
Michigan (172)
Minnesota (255)
New Jersey (1144)
New York (1068)
North Carolina (725)
Northern California (1608)
Ohio (140)
Pennsylvania (828)
South America (1024)
Southern California (1456)
Texas (528)
Washington State (392)
578,986 Results for "food and drug administration fda".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Incyte and Syndax Announce U.S. Food and Drug Administration (FDA) Approval of Niktimvo™ (axatilimab-csfr) 9 mg and 22 mg Vial Sizes
January 15, 2025
·
14 min read
Press Releases
U.S. Food and Drug Administration (FDA) accepts New Drug Application for elinzanetant
October 9, 2024
·
7 min read
Press Releases
Affimed Announces Acimtamig and AlloNK® Combination Granted Regenerative Medicine Advanced Therapy (RMAT) Designation by the U.S. Food and Drug Administration (FDA)
December 6, 2024
·
6 min read
Biotech Bay
X-Therma Announces XT-Thrive® Drug Master File (DMF) Accepted by U.S. Food and Drug Administration (FDA)
X-Therma Inc , announces that the Food and Drug Administration (FDA) accepted a Drug Master File (DMF) covering its product, XT-Thrive ® .
April 17, 2024
·
2 min read
Press Releases
Savara Initiates Rolling Submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for MOLBREEVI* for the Potential Treatment of Autoimmune Pulmonary Alveolar Proteinosis (aPAP)
December 18, 2024
·
5 min read
Press Releases
SetPoint Medical Announces Filing of Premarket Approval (PMA) Application to the U.S. Food and Drug Administration (FDA) for Novel Neuroimmune Modulation Device for the Treatment of Rheumatoid Arthritis
December 9, 2024
·
2 min read
Business
Otsuka and Click Therapeutics Announce the U.S. Food and Drug Administration (FDA) Clearance of Rejoyn
Otsuka Pharmaceutical, Co. Ltd. (Otsuka) and Click Therapeutics, Inc., (Click) announce that the U.S. Food and Drug Administration (FDA) has cleared Rejoyn.
April 1, 2024
·
12 min read
FDA
U.S. Food and Drug Administration (FDA) Approves FoundationOne®Liquid CDx as a Companion Diagnostic for AKEEGA® (niraparib and abiraterone acetate) for Patients with BRCA-Positive Metastatic Castration-Resistant Prostate Cancer
Foundation Medicine, Inc. today announced that it has received approval from the U.S. Food and Drug Administration (FDA) for FoundationOne®Liquid CDx to be used as a companion diagnostic for AKEEGA® (niraparib and abiraterone acetate) from Janssen Biotech, Inc.
July 1, 2024
·
6 min read
Press Releases
Tempest Receives Orphan Drug Designation from the U.S. Food and Drug Administration for Amezalpat to Treat Patients with Hepatocellular Carcinoma (HCC)
January 6, 2025
·
7 min read
Pharm Country
HARMONY BIOSCIENCES ACKNOWLEDGES U.S. FOOD & DRUG ADMINISTRATION (FDA) ACTION DENYING THE CITIZEN PETITION FOR WAKIX® (PITOLSIANT)
Harmony Biosciences today announced that the U.S. Food and Drug Administration denied the Citizen Petition filed by a short seller claiming that WAKIX is not safe and effective for the treatment of excessive daytime sleepiness (EDS) and cataplexy in adults with narcolepsy.
June 25, 2024
·
12 min read
1 of 57,899
Next
